Old Web
English
Sign In
Acemap
>
authorDetail
>
Thomas Müller
Thomas Müller
Exelixis
Pharmacodynamics
Oral administration
Trough Concentration
Nausea
Pharmacology
2
Papers
43
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Erratum to: A Phase 1 dose-escalation study of the safety and pharmacokinetics of once-daily oral foretinib, a multi-kinase inhibitor, in patients with solid tumors
2013
Investigational New Drugs
Geoffrey I. Shapiro
Stewart W. McCallum
Laurel M. Adams
Laurie Sherman
Steve Weller
Suzanne Swann
Harold Keer
Dale Miles
Thomas Müller
Daniel C. Rabe
Fabiola Cecchi
Donald P. Bottaro
Patricia LoRusso
Show All
Source
Cite
Save
Citations (38)
Abstract B269: Pharmacodynamic and correlative biomarker analyses in clinical trials of XL184, an oral, potent inhibitor of MET, VEGFR2, and RET
2009
Molecular Cancer Therapeutics
Thomas Müller
Samuel DePrimo
Garth Joseph Mcgrath
Peiwen Yu
Jianming Wu
Levina Goon
Michelle Lee
Anushka de Costa
Felix Chu
Belinda Cancilla
Stephen Huang
Valentina Vysotskaia
Jonathan C. Li
Lora Zhao
Mei Wong
Show All
Source
Cite
Save
Citations (5)
1